BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 36901957)

  • 1. Effects of regulatory B cells on intracranial aneurysms by mediating IL-1β/IL-1R pathways.
    Shi C; Tian F; Yang X; Song J; Qi D; Li J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):152-157. PubMed ID: 38678612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell RNA-Seq of T Cells in B-ALL Patients Reveals an Exhausted Subset with Remarkable Heterogeneity.
    Wang X; Chen Y; Li Z; Huang B; Xu L; Lai J; Lu Y; Zha X; Liu B; Lan Y; Li Y
    Adv Sci (Weinh); 2021 Oct; 8(19):e2101447. PubMed ID: 34365737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIM-3
    Minnie SA; Waltner OG; Zhang P; Takahashi S; Nemychenkov NS; Ensbey KS; Schmidt CR; Legg SRW; Comstock M; Boiko JR; Nelson E; Bhise SS; Wilkens AB; Koyama M; Dhodapkar MV; Chesi M; Riddell SR; Green DJ; Spencer A; Furlan SN; Hill GR
    Sci Immunol; 2024 Apr; 9(94):eadg1094. PubMed ID: 38640253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Cross-Training and Resistance Exercise Routine on IL-15 in Adults with Type B Acute Lymphoblastic Leukemia during the Induction Phase: Randomized Pilot Study.
    Gallardo Rodríguez AG; Olarte Carrillo I; Martínez Tovar A; Cerón Maldonado R; Martínez Moreno E; Ramos Peñafiel CO
    J Funct Morphol Kinesiol; 2023 Dec; 9(1):. PubMed ID: 38535413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases.
    Canale FP; Ramello MC; Montes CL
    Oncoscience; 2018 Mar; 5(3-4):65-66. PubMed ID: 29854871
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers.
    Carvalho MPSS; Magalhães-Gama F; Loiola BP; Neves JCF; Araújo ND; Silva FS; Catão CLS; Alves EB; Pimentel JPD; Barbosa MNS; Fraiji NA; Teixeira-Carvalho A; Martins-Filho OA; Costa AG; Malheiro A
    Front Oncol; 2023; 13():1290505. PubMed ID: 38107068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checkpoint inhibition in hematologic malignancies.
    Tsumura A; Levis D; Tuscano JM
    Front Oncol; 2023; 13():1288172. PubMed ID: 37920162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection.
    Apol ÁD; Winckelmann AA; Duus RB; Bukh J; Weis N
    Viruses; 2023 May; 15(5):. PubMed ID: 37243227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T Cell Exhaustion and Activation Markers in Pancreatic Cancer: A Systematic Review.
    Mishra S; Telang G; Bennur D; Chougule S; Dandge PB; Joshi S; Vyas N
    J Gastrointest Cancer; 2023 Sep; ():. PubMed ID: 37672169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Potential Markers of Regulatory and Exhausted CD8
    Naghavi Alhosseini M; Palazzo M; Cari L; Ronchetti S; Migliorati G; Nocentini G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
    Lim A; French MA; Price P
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.
    Horwitz DA; Pan S; Ou JN; Wang J; Chen M; Gray JD; Zheng SG
    Clin Immunol; 2013 Dec; 149(3):450-63. PubMed ID: 24211847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
    Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
    Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.